The increase of the rate of hemopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients

Neoplasma

Volumn 46, Issue 3, 1999, Pages 166-172

  Filip, S ^a   Vanasek J ^a   Blaha M ^a   Mericka P ^c   Vavrova J ^b   Podzimek, K ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b DEPARTMENT OF TOXICOLOGY   (Czech Republic)

^c NONE

Author keywords

Breast carcinoma; EPO and G CSF; Hemopoietic recovery; Hemopoietic toxicity; Intensive chemotherapy; PBPC; Progenitor cells

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEMATOPOIETIC STEM CELL; HIGH RISK POPULATION; HUMAN; LEUKOCYTE COUNT; PERIPHERAL BLOOD STEM CELL; RISK BENEFIT ANALYSIS; STEM CELL;

EID: 0345465956     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. ANTMAN, K., ARMITAGE, J.O., HOROWITZ, M.M.: Autotransplants for breast cancer in North America. Proc. Am. Soc. Clin. Oncol., 13, 1994, 69-72.
2. BEGUIN, Y., ORIS, R., FILLET, G.: Dynamics of erythropoietic recovery following bone marrow transplantation: Role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. Bone Marrow Transplant., 11, 1993, 285-292.
3. BENEDETTI, P.P., PIERELLI, L., SCAMBIA, G., FODDAI, M.L., SALERNO, M.G., MENICHELLA, G., VITTORI, M., MANESCHI, F., CARACUSSI, U., SERAFINI, R., LEONE, G., MANCUSO, S.: High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: Non-haematological, haematological toxicities and role of growth factor administration. Br. J. Cancer, 75, 1997, 1205-1212.
4. BERNELL, P., STENKE, L., WALVIK, J.: A sequential erythropoietin and granulocyte-macrophage colony-stimulating factor schedule offers clinical benefits in the treatment of anemia in myelodysplastic syndromes. Leuk. Res., 20, 1996, 693-699.
5. BESSOHO, M., TOYODA, A., ITHO, Y., SAKATA, T., KAWAI, N., JINNAI, I., SAITO, M., HIRASHIMA, K.: Trilineage recovery by combination with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEPO) in severe aplastic anemia. Br. J. Haematol., 80, 1992, 409-411.
6. BISHOP, M.R., ANDERSON, J.R., JACKSON, J.D., BIERMAN, P.J., REED, E.C., VOSE, J.M., ARMITAGE, J.O., WARKENTIN, P.I., KESSINGER, A.: High-dose therapy and peripheral blood progenitor cell transplantation: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood, 83, 1994, 610-616.
7. BRUGER, W., BROSS, K., FRISCH, J., DERN, P., WEBER, B., MERTELSMAN, R., KANZ, L.: Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood, 97, 1992, 1193-1200.
8. CHAO, N.J., SCHRIBER, J.R., LONG, G.D., NEGRIN, R.S., CATOLICO, M., BROWN, B.W., MILLER, L.L., BLUME, K.G.: A randomized study of erythropoietin and granulocyte colony/stimulating factor (G/CSF) versus placebo and G/CSF for patients with Hodgking's and non/Hodgkin's lymphoma undergoing autologous bone marrow transplantation. Blood, 83, 1994, 2823-2828.
9. DERMIRER, T., BENSINGER, W.I.: Optimalization of peripheral blood stem cell collection. Curr. Opin. Hematol., 2, 1995, 219-226.
10. DESSYPRIS, E.N., GRABER, S.E., KRANTZ, S.B., STONE, W.J.: Effects of recombinant erythropoietin on the concentration and cycling status of human hematopoietic progenitor cells in vivo. Blood, 72, 1988, 2060-2062.
11. FENELLY, D., VAHDAT, L., SCHNEIDER, J.: High-intensity chemotherapy with peripheral blood progenitor cell support. Semin. Oncol., 21, 1994, 21-25.
12. FILIP, S., VAŇÁSEK, J., BLÁHA, M., VÁVROVÁ, J.: Circulation of progenitor cells after intensive chemotherapy followed by combination G-CSF and EPO in breast carcinoma. Neoplasma, 44, 1997, 212-218.
13. GANSER, M., BERGMANN, M., VOLKERS, B., GRUTZMACHER, P., SCIGALLA, P., HOELZER, D.: In vivo effects of recombinant human erythropoietin on circulation human hemopoietic progenitor cells. Exp. Hematol., 17, 1989, 433-435.
14. HENON, P.R., LIAG, H., BECK-WIRTH, G., EISENMANN, J.C., LEPERS, M., WUNDER, E., KANDEL, G.: Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant., 9, 1992, 285-291.
15. HINO, M., MIYAZONO, K., URABE, A., TAKAKU, F.: Effect of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo. Int. J. Cell. Cloning, 7, 1989, 257-262.
16. JONES, H.M., JONES, S.A., WATTS, M.J., KHWAJA, A., MILLS, W., FIELDING, A., GOLDSTONE, A.H., LINCH, D.C.: Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J. Clin. Oncol., 12, 1994, 1693-1702.
17. KRÖGER, N., ZSCHABER, R., KRÜGER, W.: Dose intensity of chemotherapy in breast cancer. Results of clinical studies. Onkologie, 18, 1995, 419-428.
18. LAZARUS, H.M.: Hematopoietic progenitor cell transplantation in breast cancer: Current status and future directions. Cancer Invest., 16, 1998, 1-25.
19. LOCATELLI, F., ZECCA, M., BONETTI, F., PONCHIO, L., GIORGIANI, G., DE STEFANO, P., CAZZOLLA, M.: Combined administration of erythropoietin and granulocyte-colony stimulating factor (G-CSF) to children after allogeneic bone marrow transplantation (BMT) accelerates trilineage marrow reconstitution. Blood, Suppl. 1, 82, 1993, 285.
20. MENICHELLA, G., PIERELLI, L., SCAMBIA, G., SALERNO, G., BENEDETTI PANICI, P., FODDAI, M.L., SERAFINI, R., PUGLIA, G., LAI, M., CIARLI, M., MANCUSCO, S., BIZZINI, B.: Low-dose cyclophosphamide in combination with cisplatin or epirubicin plus rhG-CSF allows adequate collection of PBSC for autotransplantation during adjuvant therapy for high-risk cancer. Bone Marrow Transplant., 67, 1994, 907-912.
21. METCALF, D.: The molecular biology and cloning of the granulocyte-macrophage colony-stimulating factor. Blood, 67, 1986, 257-267.
22. MILES, S.A., MITSUYASU, R.T., MORENO, J., BALDWIN, G., ALTON, N.K., SOUZA, L., GLASPY, J.A.: Combined therapy recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from Zidovudine. Blood, 77, 1991, 2109-2117.
23. NEGRIN, R.S., STEIN, R., DOBERTYK., CRONWELL, J., VARDINAN, J., KRANTZ, S., GREENBERG, P.L.: Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: Evidence for in vivo synergy. Blood, 87, 1996, 4076-4081.
24. OBERHOFF C.: Reduction of transfusion requirement and treatment of chemotherapy-induced anemia with recombinant human erythropoietin (Epoetin Beta) in patients with solid malignant tumors. Care Oncol., Suppl., 27, 5-8.
25. OLIVIERI, A., OFFIDANI, M., CANTORI, I., CANTORI, L., CINIERO, L., OMBROSI, L., MASIA, M.C., BRUNORI, M., MONTRONI, M., LEONI, P.: Addition of erythropoieitin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. Bone Marrow Transplant., 16, 1995, 765-770.
26. PETTENGEL, R., WOLL, P.J., CHANG, J., COUNTINHO, L., TESTA, N.G., CROWTHER, D.: Effect of erythropoietin on mobilization of hemopoietic progenitor cells. Bone Marrow Transplantant., 14, 1994, 125-130.
27. PETTENGELL, R., WHOL, P.J., TATCHER, N., DEXTER, M.T., TESTA, N.G.: Multicyclic dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J. Clin. Oncol., 13, 1995, 148-156.
28. PIERELLI, L., SCAMBIA, G., MENICHELLA, G.,D'ONOFRIO, G., SALERNO, G., PANICI, B.P., FODDAI, M.L., VITTORI, M., LAI, M., CIARLI, M., PUGLIA, G., MANCUSO, S., BIZZI, B.: The combination of erythropoieitin and granulocyte colony-stimulating factor increases the rate of hemopoietic recovery with clinical benefit after peripheral blood progenitor cell transplantation. Br. J. Hematol., 92, 1996, 287-294.
29. SHERIDAN, W.P.: The role of colony-stimulating factors in bone marrow transplantation. Cancer Invest., 9, 1991, 221-228.
30. SHERIDAN, W.P., BEGLEY, C.G., JUTTNER, C.A.: Effect of peripheral blood progenitor cells mobilised by G-CSF (filgrastim) on platelet recovery after high-dose chemotherapy. Lancet, 339, 1992, 640-644.
31. SHIMAZAKI, C., OKU, N., UCHIYAMA, H., YAGAMATA, N., TATSUMI, T., HIRATA, T., ASHISHARA, E., OKAWA, K., GOTO, H., INADA, T., FUJITA, N., HARUYAMA, H., NAKAGAWA, M.: Effect of granulocyte-colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation. Bone Marrow Transplant., 13, 1994, 271-275.
32. SPAËTH, D., MARCHAL, C., BLANC-VINCENT, M.P.: Standards options et recommandations pour l'utilisation de l'rérythropoiétine en cancérologie. Bull. Cancer, 85, 1998, 337-346.
33. SPITZER, G., ADKINS, R.D., SPENCER, V., DUNPHY, F.R., PETRUSKA, P.J., VELASQUEZ, W.S., BOWERS, C.E., KRONMULLER, N., NIEMEYER, R., MCINTYRE, W.: Randomized study of growth factors post-peripheral-blood stem-cell transplant: Neutrophil recovery is improved with modest clinical benefit. J. Clin. Oncol., 12, 1994, 661-670.
34. SPIVAK, J.L.: The biology and clinical application of recombinant erythropoietin. Semin. Oncol., 25, 1998, 7-11.
35. VANNUCCHI, A.M., BOSI, A., IERI, A., GUIDI, S., SACCARDI, R., LOMBARDI, L., LINARI, S., LASZLO, D., LONGO, G., ROSSI-FERRINI, P.: Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: A randomized trial. Bone Marrow Transplant., 17, 1996, 527-531.